相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease
Maria Poplawska et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
Prashant Singh et al.
GUT MICROBES (2022)
Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Raseen Tariq et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)
High incidence of healthcare facility-acquiredClostridium difficileinfections in chronic opioid users
Michael Lichtbroun et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry
Colleen R. Kelly et al.
GASTROENTEROLOGY (2021)
Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection A Systematic Review and Meta-Analysis
Charles Du et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers
Felix Goeser et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
Ye Zhao et al.
FRONTIERS IN IMMUNOLOGY (2021)
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
Simon Mark Dahl Baunwall et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
Antibiotic Prescribing and Respiratory Viral Testing for Acute Upper Respiratory Infections Among Adult Patients at an Ambulatory Cancer Center
Elizabeth M. Krantz et al.
CLINICAL INFECTIOUS DISEASES (2020)
Rifaximin on intestinally-related pathologic changes in sickle cell disease
Dibyendu Dutta et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease
Seah H. Lim et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
Richard L. Hengel et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation
Chunliang Xu et al.
IMMUNITY (2020)
Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients
Yannouck F. van Lier et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules A case report
Dan Mao et al.
MEDICINE (2020)
Fecal Microbiota Transplants Annually and Their Positive Clinical Impact
Lamia Mamoon et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives
Michael Napolitano et al.
FRONTIERS IN MICROBIOLOGY (2020)
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis
Simon Mark Dahl Baunwall et al.
ECLINICALMEDICINE (2020)
Intestinal injury and gut permeability in sickle cell disease
Dibyendu Dutta et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato et al.
JAMA ONCOLOGY (2019)
Rifaximin for sickle cell disease
Seah H. Lim et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease
Pan Li et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
Bruno K. Rodino-Janeiro et al.
ADVANCES IN THERAPY (2018)
Intestinal microbiome analysis revealed dysbiosis in sickle cell disease
Seah H. Lim et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLRLI/TNF-α signaling pathway
Meng-Fei Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study
A. Dinh et al.
JOURNAL OF HOSPITAL INFECTION (2018)
Fecal microbiota transplantation in refractory or recurrent Clostridium difficile infection: a real-life experience in a non-academic center
Ana Ponte et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2018)
Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model
Fuyuan Wang et al.
SCIENTIFIC REPORTS (2018)
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
Xiaofei Qi et al.
FRONTIERS IN IMMUNOLOGY (2018)
The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
Tarek Mazzawi et al.
PLOS ONE (2018)
Fecal transplantation for treatment of inflammatory bowel disease
Aamer Imdad et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
M. Schmidt-Hieber et al.
ANNALS OF HEMATOLOGY (2018)
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Christopher Staley et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
European consensus conference on faecal microbiota transplantation in clinical practice
Giovanni Cammarota et al.
GUT (2017)
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease
Walter Spindelboeck et al.
HAEMATOLOGICA (2017)
Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection A Collaborative Analysis of Individual Patient Data From 14 Studies
Luis Furuya-Kanamori et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Sudarshan Paramsothy et al.
JOURNAL OF CROHNS & COLITIS (2017)
Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
Li Wen et al.
JOURNAL OF NUTRITION (2017)
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
Kerstin Berer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization
Shou K. Ji et al.
FRONTIERS IN MICROBIOLOGY (2017)
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease
Walter Spindelboeck et al.
HAEMATOLOGICA (2017)
Risk factors for Clostridium difficile infections-an overview of the evidence base and challenges in data synthesis
Paul Eze et al.
JOURNAL OF GLOBAL HEALTH (2017)
Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study
Dae-Wook Kang et al.
MICROBIOME (2017)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
The gut microbiota and host health: a new clinical frontier
Julian R. Marchesi et al.
GUT (2016)
IMPLICATION OF GUT MICROBIOTA IN DIABETES MELLITUS AND OBESITY
I. Grigorescu et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2016)
Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant
Aya Agha et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut
Kazuhiko Kakihana et al.
BLOOD (2016)
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
Ilan Youngster et al.
BMC MEDICINE (2016)
Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota
Zhaoyuan Peng et al.
ENDOSCOPY INTERNATIONAL OPEN (2016)
Diagnosis and Treatment of Clostridium difficile in Adults A Systematic Review
Natasha Bagdasarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Fecal Microbiota Transplant
Lawrence J. Brandt
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Weight Gain After Fecal Microbiota Transplantation
Neha Alang et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Clostridium Difficile Infection after Allogeneic Hematopoietic Stem Cell Transplant: Strain Diversity and Outcomes Associated with NAP1/027
Mini Kamboj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Irinotecan disrupts tight junction proteins within the gut Implications for chemotherapy-induced gut toxicity
Hannah R. Wardill et al.
CANCER BIOLOGY & THERAPY (2014)
Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease
R. Singh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy
Young Kyung Yoon et al.
SUPPORTIVE CARE IN CANCER (2014)
Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
Sailajah Janarthanan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome
Lise Willems et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
The economic burden of Clostridium difficile
S. M. McGlone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
Johan S. Bakken et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study
P. Tsirigotis et al.
BONE MARROW TRANSPLANTATION (2008)
The gut microbiota as an environmental factor that regulates fat storage
F Bäckhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
More on Merde
RA Lewin
PERSPECTIVES IN BIOLOGY AND MEDICINE (2001)
分享论文
